Your session is about to expire
← Back to Search
Procedure
Transcranial Magnetic Stimulation for Brain Tumor
N/A
Waitlist Available
Led By Sarah Prinsloo
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights
Study Summary
This trial studies if navigated repetitive transcranial magnetic stimulation can help improve patients' lost motor function after surgery for a brain tumor.
Who is the study for?
This trial is for individuals with brain tumors affecting motor function, who have had recent surgery related to the motor cortex. Participants must be able to understand English, consent in writing, and follow the study's procedures. They should not be on antipsychotic meds or have a history of stroke or severe psychiatric conditions like bipolar disorder or schizophrenia.Check my eligibility
What is being tested?
The trial is examining how well navigated repetitive transcranial magnetic stimulation (nrTMS) can help improve movement abilities that were lost due to brain tumor surgery. Patients will receive nrTMS sessions and their motor rehabilitation progress will be monitored.See study design
What are the potential side effects?
While specific side effects are not detailed here, nrTMS is generally considered safe but may cause discomfort at the stimulation site, headache, lightheadedness, or seizures in very rare cases.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intervention adherence
Other outcome measures
Changes in cortical activity
Motor recovery
Trial Design
1Treatment groups
Experimental Treatment
Group I: Supportive care (nrTMS)Experimental Treatment2 Interventions
Between 1-7 days after standard of care surgery, participants undergo 10 nrTMS sessions over 30 minutes each over 3 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Magnetic Stimulation
2017
Completed Phase 4
~730
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,967 Previous Clinical Trials
1,804,770 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,635 Total Patients Enrolled
Sarah PrinslooPrincipal InvestigatorM.D. Anderson Cancer Center
6 Previous Clinical Trials
818 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My surgeon will decide if I can have nrTMS treatment based on my motor skills after surgery.I had surgery near the brain's movement control area within the last week.You have been diagnosed with bipolar disorder or schizophrenia in the past.I am currently taking antipsychotic medication.My brain tumor is near the area that controls movement.My movement issues are due to my surgery or cancer, according to my doctor.I can take care of myself and am up and about more than half of my waking hours.I have had a stroke in the past.
Research Study Groups:
This trial has the following groups:- Group 1: Supportive care (nrTMS)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are individuals currently being enrolled in this experiment?
"This research endeavour, which was first posted on August 23rd 2018 and last revised July 18th 2022, is no longer recruiting participants. However, there are still 408 other trials actively looking for patients at the time of this writing."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger